Science, Scientific Research, Rare Disease.
government, industry and academia. Lower the Hurdles Emil Kakkis, MD, PhD, the founder and CEO of Ultragenyx Pharmaceutical, and also the founder of the EveryLife Foundation for Rare Diseases, said regulatory hurdles “threaten the potential that we may not be able to use all the science we have to